Project Grant HT94252510652
Award Date 9/30/25
Completion Date 9/29/29
Dollars Obligated $1.6M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
San Antonio, TX 78229, USA
Similar Awards
- This federal Project Grant award of $1,181,251.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the development of a Computerized Anger Management Protocol (CAMP) for service members with and without a history of mild traumatic brain injury. The University of Texas Health Science Center at San Antonio, a prominent Hispanic-serving academic medical center, is conducting this research project that aims to transform healthcare for military...
- The Defense Health Agency awarded a $3,150,000 Project Grant to the University of Texas Health Science Center at San Antonio (UTHSCSA) under the Military Medical Research and Development program (CFDA 12.420). The grant supports a randomized clinical trial using noninvasive brain stimulation combined with written exposure therapy for post-traumatic stress disorder (PTSD) in military personnel with mild traumatic brain injury. The project will be performed in San Antonio, TX and runs from...
- The University of Texas Health Science Center at San Antonio (UTHSCSA) received a $508,815 Cooperative Agreement award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to implement and evaluate a patient-centered PTSD treatment program for military personnel. This 4-year award, running from September 1, 2023 to August 31, 2027, will support research to transform healthcare for service members and the public through innovative and...
- This $1,872,750.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research by The University of Texas Health Science Center at San Antonio (UTHSCSA) to develop the anti-prostate cancer agent Selisistat for the treatment of prostate cancer. The award, which runs from June 1, 2025 to May 31, 2028, will fund UTHSCSA's research to transform healthcare for military service members, veterans, and the...
- The University of Texas Health Science Center at San Antonio (UTHSCSA) was awarded a $493,610 Project Grant from the Department of Defense's Military Medical Research and Development (CFDA 12.420) program to conduct a randomized clinical trial utilizing crisis response planning for suicide prevention in military personnel with traumatic brain injury. The grant, awarded on August 1, 2024, will support this research project over a 3-year period, with a final completion date of July 31, 2027. As...
- The Defense Health Agency awarded a $2,519,334 Project Grant to The University of Texas Health Science Center at San Antonio (UTHSCSA) to develop and conduct a clinical trial of an AI-facilitated, web-based written exposure therapy training program to increase the reach of evidence-based PTSD treatment. The project falls under the Military Medical Research and Development federal grant program (CFDA 12.420), which supports biomedical research to transform healthcare for military service members,...
- The Defense Health Agency awarded a $2,788,886 Project Grant to the University of Texas Health Science Center at San Antonio (UTHSCSA) on September 30, 2025 under the Military Medical Research and Development federal grant program (CFDA 12.420). The purpose of this 4-year grant is to support a multisite pilot randomized clinical trial to disseminate the SCIPI (Support, Communication, and Information) program to men with localized prostate cancer. As a prominent Hispanic-serving academic...
- This $1,124,825 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will support research at the University of Texas Health Science Center at San Antonio (UTHSCSA) to identify novel therapeutic targets for aggressive prostate cancer through induced pluripotent stem cell modeling of BRCA2 mutant prostate tissue. The award, which runs from August 1, 2024 to July 31, 2027, will enable UTHSCSA to conduct innovative scientific...
- The Defense Health Agency awarded a four-year, $936,532 Cooperative Agreement to the University of Texas Health Science Center at San Antonio (UTHSCSA) to implement and evaluate a patient-centered PTSD treatment program for military personnel. This award is funded under the Military Medical Research and Development (CFDA 12.420) program, which supports biomedical research to transform healthcare for service members and the public. Through this Cooperative Agreement, UTHSCSA will conduct research...
- The University of Texas Health Science Center of San Antonio will receive $123,599 through a Cooperative Agreement awarded by the Department of the Army Medical Command on September 30, 2022. The funding supports the Assessment and Treatment of Chronic Anger and Aggression Following Military-Related Interpersonal and Institutional Betrayal pilot investigation. This project addresses the Military Medical Research and Development program's goal of innovative medical solutions for Service Members...